{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-033923","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2024-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.234759+00:00","generated_at":"2026-06-04T22:05:48.934026+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cognition Therapeutics raises ~$10.4M in public offering of 6.57M shares at $1.75","bullets":["Issued 6,571,428 shares of common stock at $1.75 per share; net proceeds ~$10.4M after expenses.","Underwriter granted 30-day option to buy up to 985,714 additional shares at the same price.","Offering expected to close March 14, 2024; funds to be used for R&D, clinical development, manufacturing, and working capital.","Directors and executive officers subject to lock-up agreements prohibiting share sales until May 13, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-033923","json":"https://secwatch.observer/filing/0001104659-24-033923.json","markdown":"https://secwatch.observer/filing/0001104659-24-033923.md","text":"https://secwatch.observer/filing/0001104659-24-033923.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924033923/0001104659-24-033923-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924033923/tm248691d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T22:05:48.934026+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"602c8a41a4b1ffdf3a701e4c7210912733464c0a","claim":"COGNITION THERAPEUTICS INC entered into Underwriting Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (effective 2024-03-11).","evidence_excerpt":"On March 11, 2024, Cognition Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC (the “Underwriter”), pursuant to which the Company agreed to issue and sell to the Underwriter, in a public offering (the “Offering”), 6,571,428 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”) at a public offering price of $1.75 per share (the “Offering Price”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924033923/0001104659-24-033923-index.htm","confidence":0.98,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Titan Partners Group LLC, a division of American Capital Partners, LLC"},{"label":"Effective","value":"2024-03-11"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}